The Oncosearch | Oncotarget

The nuclear envelope and metastasis Editorial

Emily Hansen, James M. Holaska

Published Feb 17, 2023 · Vol. 14, No. 1 · pp. 317-320

Keywords: emerin, metastasis, mechanotransduction, breast cancer, nucleoskeleton

A balancing act: how whole-genome doubling and aneuploidy interact in human cancer Editorial

Kavya Prasad, Uri Ben-David

Published Feb 17, 2023 · Vol. 14, No. 1 · pp. 382-383

Keywords: cancer, cancer genetics, whole-genome doubling, chromosomal instability

The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer Editorial

Brian Diskin, Sarah Schwartz, George Miller

Published Feb 16, 2023 · Vol. 14, No. 1 · pp. 364-365

Keywords: pancreatic cancer, liver metastasis, immunnotherapy

Mitochondria engage the integrated stress response to promote tumor growth Editorial

Dillon P. Boulton, M. Cecilia Caino

Published Feb 16, 2023 · Vol. 14, No. 1 · pp. 150-152

Keywords: mitochondria, prostate cancer, integrated stress response

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis? Editorial

Laura Garcia-Gerique, Yulia Nefedova

Published Feb 16, 2023 · Vol. 14, No. 1 · pp. 258-260

Keywords: PAD4, PMN-MDSC, neutrophils, neutrophil migration

Leakage? or Secretion? unconventional protein secretion in cancer Editorial Perspective

Kohji Yamada, Kiyotsugu Yoshida

Published Feb 16, 2023 · Vol. 14, No. 1 · pp. 146-147

Keywords: unconventional protein secretion, cancer, endoplasmic reticulum

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Christian Mark Farag, Ryan Antar, Sinan Akosman, Matthew Ng, Michael J. Whalen

Published Feb 15, 2023 · Vol. 14, No. 1 · pp. 153-172

Keywords: HALP score, biomarker, prognosis, cancer, survival

Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment Addendum

Gennady M. Zharinov, Oleg A. Bogomolov, Irina V. Chepurnaya, Natalia Yu. Neklasova, Vladimir N. Anisimov

Published Feb 7, 2023 · Vol. 14, No. 1 · pp. 149-149

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Clark G. Wang, Malalage N. Peiris, April N. Meyer, Katelyn N. Nelson, Daniel J. Donoghue

Published Feb 6, 2023 · Vol. 14, No. 1 · pp. 133-145

Keywords: oncogenic fusion protein, chromosomal translocation, glioblastoma, FGFR3-TACC3, coiled-coil

Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer Correction

Keisuke Taniuchi, Mitsunari Ogasawara

Published Feb 3, 2023 · Vol. 14, No. 1 · pp. 104-104

The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles Research Paper

Martin Chevarin, Diana Alcantara, Juliette Albuisson, Marie-Agnès Collonge-Rame, Céline Populaire, Zohair Selmani, Amandine Baurand, Caroline Sawka, Geoffrey Bertolone, Patrick Callier, Yannis Duffourd, Philippe Jonveaux, Yves-Jean Bignon, Isabelle Coupier, François Cornelis, Christophe Cordier, Monique Mozelle-Nivoix, Jean-Baptiste Rivière, Paul Kuentz, Christel Thauvin, Romain Boidot, François Ghiringhelli, Marc O'Driscoll, Laurence Faivre, Sophie Nambot

Published Feb 1, 2023 · Vol. 14, No. 1 · pp. 111-125

Keywords: male breast cancer, genetic predisposition to cancer, exome sequencing, ATR, extreme phenotype

Unveiling the non-canonical functions of EZH2 in prostate cancer Editorial

Yang Yi, Yanqiang Li, Kaifu Chen, Qi Cao

Published Jan 27, 2023 · Vol. 14, No. 1 · pp. 127-128

Keywords: EZH2, prostate cancer, FBL, CDCA8, E2F1

Correction: UBE2T knockdown inhibits gastric cancer progression Correction

Changjiang Luo, Yunyi Yao, Zeyuan Yu, Huinian Zhou, Lingyun Guo, Junqiang Zhang, Hongtai Cao, Genyuan Zhang, Yumin Li, Zuoyi Jiao

Published Jan 27, 2023 · Vol. 14, No. 1 · pp. 188-189

Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC) Research Paper

Md Maksudul Alam, Janmaris Marin Fermin, Mark Knackstedt, Mackenzie J. Noonan, Taylor Powell, Landon Goodreau, Emily K. Daniel, Xiaohua Rong, Tara Moore-Medlin, Alok R. Khandelwal, Cherie-Ann O. Nathan

Published Jan 27, 2023 · Vol. 14, No. 1 · pp. 85-95

Keywords: TP53 mutant, HNSCC, angiogenesis, everolimus, mTOR

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy Research Perspective

Anqi Shao, David M. Owens

Published Jan 27, 2023 · Vol. 14, No. 1 · pp. 96-103

Keywords: CD200 receptor, oncoimmunology, immunotherapy, tumor microenvironment, immune checkpoint inhibition

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima

Published Jan 25, 2023 · Vol. 14, No. 1 · pp. 71-82

Keywords: gastric cancer, laparoscopic gastrectomy, novel predictive index, inflammation-combined prognostic index, cancer-specific survival

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659) Research Paper

Leo I. Gordon, Reem Karmali, Jason B. Kaplan, Rakesh Popat, Howard A. Burris III, Silvia Ferrari, Sumit Madan, Manish R. Patel, Giuseppe Gritti, Dima El-Sharkawi, F. Ian Chau, John Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan P. Iyer, William Townsend, Harry Miao, Igor Proscurshim, Shining Wang, Shilpi Katyayan, Ying Yuan, Jiaxi Zhu, Kate Stumpo, Yaping Shou, Cecilia Carpio, Francesc Bosch

Published Jan 20, 2023 · Vol. 14, No. 1 · pp. 57-70

Keywords: Non-Hodgkin’s lymphoma, DLBCL, relapsed/refractory, SYK inhibitor, TAK-659

The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system Editorial

Munemasa Nagao, Akihisa Fukuda, Hiroshi Seno

Published Jan 17, 2023 · Vol. 14, No. 1 · pp. 54-56

Keywords: ICPN, BilIN, biliary cancer, Kras, Wnt

Correction: TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells Correction

Wenqian Li, Xiaoxue Zhang, Ji Wang, Mengchen Li, Canhui Cao, Jiahong Tan, Ding Ma, Qinglei Gao

Published Jan 14, 2023

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma Correction

Yonghao Zhan, Yifan Li, Bao Guan, Xiaoying Chen, Zhicong Chen, Anbang He, Shiming He, Yanqing Gong, Ding Peng, Yuchen Liu, Zhiming Cai, Xuesong Li, Liqun Zhou

Published Jan 14, 2023 · Vol. 14, No. 1 · pp. 210-210

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

The nuclear envelope and metastasis Editorial

A balancing act: how whole-genome doubling and aneuploidy interact in human cancer Editorial

The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer Editorial

Mitochondria engage the integrated stress response to promote tumor growth Editorial

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis? Editorial

Leakage? or Secretion? unconventional protein secretion in cancer Editorial Perspective

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment Addendum

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer Correction

The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles Research Paper

Unveiling the non-canonical functions of EZH2 in prostate cancer Editorial

Correction: UBE2T knockdown inhibits gastric cancer progression Correction

Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC) Research Paper

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659) Research Paper

The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system Editorial

Correction: TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells Correction

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma Correction

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

The nuclear envelope and metastasis Editorial

A balancing act: how whole-genome doubling and aneuploidy interact in human cancer Editorial

The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer Editorial

Mitochondria engage the integrated stress response to promote tumor growth Editorial

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis? Editorial

Leakage? or Secretion? unconventional protein secretion in cancer Editorial Perspective

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment Addendum

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer Correction

The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles Research Paper

Unveiling the non-canonical functions of EZH2 in prostate cancer Editorial

Correction: UBE2T knockdown inhibits gastric cancer progression Correction

Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC) Research Paper

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659) Research Paper

The role of Kras and canonical Wnt pathways for tumorigenesis of extrahepatic biliary system Editorial

Correction: TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells Correction

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma Correction